Surmodics (SRDX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Surmodics Revenue Highlights

Latest Revenue (Y)

$132.58M

Latest Revenue (Q)

$30.34M

Main Segment (Y)

Royalty

Surmodics Revenue by Period

Surmodics Revenue by Year

Date	Revenue	Change
2023-09-30	$132.58M	32.65%
2022-09-30	$99.95M	-4.93%
2021-09-30	$105.14M	10.83%
2020-09-30	$94.86M	-5.21%
2019-09-30	$100.08M	23.04%
2018-09-30	$81.34M	11.25%
2017-09-30	$73.11M	2.45%
2016-09-30	$71.37M	15.30%
2015-09-30	$61.90M	7.76%
2014-09-30	$57.44M	2.33%
2013-09-30	$56.13M	8.10%
2012-09-30	$51.93M	-23.39%
2011-09-30	$67.78M	-3.03%
2010-09-30	$69.90M	-42.49%
2009-09-30	$121.53M	25.23%
2008-09-30	$97.05M	32.65%
2007-09-30	$73.16M	4.69%
2006-09-30	$69.88M	12.03%
2005-09-30	$62.38M	25.42%
2004-09-30	$49.74M	15.05%
2003-09-30	$43.23M	46.61%
2002-09-30	$29.49M	29.94%
2001-09-30	$22.69M	24.15%
2000-09-30	$18.28M	35.40%
1999-09-30	$13.50M	37.76%
1998-09-30	$9.80M	-

Surmodics generated $132.58M in revenue during NA 2023, up 32.65% compared to the previous quarter, and up 163.01% compared to the same period a year ago.

Surmodics Revenue by Quarter

Date	Revenue	Change
2024-06-30	$30.34M	-5.06%
2024-03-31	$31.96M	4.60%
2023-12-31	$30.55M	9.23%
2023-09-30	$27.97M	-46.71%
2023-06-30	$52.48M	92.97%
2023-03-31	$27.20M	9.08%
2022-12-31	$24.93M	-4.06%
2022-09-30	$25.99M	4.56%
2022-06-30	$24.85M	-4.80%
2022-03-31	$26.11M	13.49%
2021-12-31	$23.00M	-4.04%
2021-09-30	$23.97M	0.41%
2021-06-30	$23.87M	-31.78%
2021-03-31	$34.99M	56.95%
2020-12-31	$22.30M	-1.09%
2020-09-30	$22.54M	-16.14%
2020-06-30	$26.88M	17.79%
2020-03-31	$22.82M	0.91%
2019-12-31	$22.62M	-26.61%
2019-09-30	$30.82M	26.59%
2019-06-30	$24.34M	7.36%
2019-03-31	$22.68M	1.96%
2018-12-31	$22.24M	-3.46%
2018-09-30	$23.04M	3.65%
2018-06-30	$22.23M	16.63%
2018-03-31	$19.06M	12.02%
2017-12-31	$17.01M	-15.18%
2017-09-30	$20.06M	12.75%
2017-06-30	$17.79M	1.64%
2017-03-31	$17.50M	-1.45%
2016-12-31	$17.76M	-2.16%
2016-09-30	$18.15M	-9.10%
2016-06-30	$19.97M	19.60%
2016-03-31	$16.70M	0.96%
2015-12-31	$16.54M	-4.73%
2015-09-30	$17.36M	9.11%
2015-06-30	$15.91M	10.40%
2015-03-31	$14.41M	1.48%
2014-12-31	$14.21M	-7.37%
2014-09-30	$15.34M	4.93%
2014-06-30	$14.62M	7.44%
2014-03-31	$13.60M	-2.01%
2013-12-31	$13.88M	-2.90%
2013-09-30	$14.30M	0.06%
2013-06-30	$14.29M	4.34%
2013-03-31	$13.70M	-1.13%
2012-12-31	$13.85M	0.06%
2012-09-30	$13.84M	-0.83%
2012-06-30	$13.96M	14.32%
2012-03-31	$12.21M	2.47%
2011-12-31	$11.92M	-30.53%
2011-09-30	$17.15M	-4.54%
2011-06-30	$17.97M	2.70%
2011-03-31	$17.49M	15.33%
2010-12-31	$15.17M	-2.45%
2010-09-30	$15.55M	-16.44%
2010-06-30	$18.61M	1.35%
2010-03-31	$18.36M	5.63%
2009-12-31	$17.38M	-9.51%
2009-09-30	$19.21M	5.61%
2009-06-30	$18.19M	-13.09%
2009-03-31	$20.93M	-66.90%
2008-12-31	$63.22M	172.03%
2008-09-30	$23.24M	-4.27%
2008-06-30	$24.28M	-5.57%
2008-03-31	$25.71M	-

Surmodics generated $30.34M in revenue during Q3 2024, up -5.06% compared to the previous quarter, and up 111.56% compared to the same period a year ago.

Surmodics Revenue Breakdown

Surmodics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Product	$60.61M	$54.62M	$46.48M	$44.32M	$40.22M
Royalty	$62.40M	$36.25M	$47.06M	$40.63M	$48.46M
Research Development And Other	$9.57M	$9.08M	$11.60M	$9.91M	$11.40M

Surmodics's latest annual revenue breakdown by segment (product or service), as of Sep 23: Royalty (47.06%), Product (45.72%), and Research Development And Other (7.22%).

Quarterly Revenue by Product

Product/Service	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Research Development And Other	$2.32M	$2.45M	$2.55M	$2.56M	$2.66M	$2.42M	$1.93M	$2.08M	$2.14M	$2.30M	$2.56M	$2.59M	$2.99M	$3.16M	$2.86M	$2.09M	$2.50M	$2.83M	$2.49M	$3.30M
Royalty	$10.46M	$11.41M	$9.18M	$10.05M	$34.15M	$9.43M	$8.77M	$9.51M	$8.79M	$9.84M	$8.10M	$8.87M	$8.80M	$20.05M	$9.33M	$9.87M	$12.40M	$8.22M	$10.15M	$16.81M
Product	$17.56M	$18.10M	$18.83M	$15.36M	$15.67M	$15.35M	$14.23M	$14.39M	$13.92M	$13.96M	$12.34M	$12.51M	$12.08M	$11.78M	$10.10M	$10.59M	$11.99M	$11.77M	$9.97M	$10.71M

Surmodics's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (57.88%), Royalty (34.47%), and Research Development And Other (7.65%).

Surmodics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	$1.60B	$746.27M
CNMD	CONMED	$1.24B	$316.70M
LIVN	LivaNova	$1.15B	$318.11M
INGN	Inogen	$315.66M	$88.83M
FNA	Paragon 28	$216.39M	$61.02M
ANIK	Anika Therapeutics	$166.66M	$38.75M
AXGN	AxoGen	$159.01M	$48.64M
KIDS	OrthoPediatrics	$148.73M	$52.80M
SIBN	SI-BONE	$138.89M	$40.34M
SRDX	Surmodics	$132.58M	$30.34M
SGHT	Sight Sciences	$81.06M	$20.16M
LUNG	Pulmonx	$68.67M	$20.39M
NPCE	NeuroPace	$65.42M	$21.06M
APYX	Apyx Medical	$52.35M	$16.02M
OSA	ProSomnus	$27.65M	$7.46M
OFIX	Orthofix Medical	$100.00K	$198.62M

SRDX Revenue FAQ

What is Surmodics’s yearly revenue?

Surmodics's yearly revenue for 2023 was $132.58M, representing an increase of 32.65% compared to 2022. The company's yearly revenue for 2022 was $99.95M, representing a decrease of -4.93% compared to 2021. SRDX's yearly revenue for 2021 was $105.14M, representing an increase of 10.83% compared to 2020.

What is Surmodics’s quarterly revenue?

Surmodics's quarterly revenue for Q3 2024 was $30.34M, a -5.06% decrease from the previous quarter (Q2 2024), and a -42.19% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $31.96M, a 4.60% increase from the previous quarter (Q1 2024), and a 17.50% increase year-over-year (Q2 2023). SRDX's quarterly revenue for Q1 2024 was $30.55M, a 9.23% increase from the previous quarter (Q4 2023), and a 22.54% increase year-over-year (Q1 2023).

What is Surmodics’s revenue growth rate?

Surmodics's revenue growth rate for the last 3 years (2021-2023) was 26.11%, and for the last 5 years (2019-2023) was 32.48%.

What are Surmodics’s revenue streams?

Surmodics's revenue streams in p 23 are Product, Royalty, and Research Development And Other. Product generated $60.61M in revenue, accounting 45.72% of the company's total revenue, up 10.97% year-over-year. Royalty generated $62.4M in revenue, accounting 47.06% of the company's total revenue, up 72.14% year-over-year. Research Development And Other generated $9.57M in revenue, accounting 7.22% of the company's total revenue, up 5.40% year-over-year.

What is Surmodics’s main source of revenue?

For the fiscal year ending Sep 23, the largest source of revenue of Surmodics was Royalty. This segment made a revenue of $62.4M, representing 47.06% of the company's total revenue.